Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Aminohippurate sodium
Drug ID BADD_D00108
Description The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]
Indications and Usage Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.
Marketing Status Discontinued
ATC Code V04CH30
DrugBank ID DB00345
KEGG ID D01421
MeSH ID D010130
PubChem ID 443971
TTD Drug ID D06OAV
NDC Product Code Not Available
Synonyms p-Aminohippuric Acid | p Aminohippuric Acid | para-Aminohippuric Acid | para Aminohippuric Acid | 4-Aminohippuric Acid | 4 Aminohippuric Acid | Aminohippuric Acid | Nephrotest | p-Aminohippurate | p Aminohippurate | Aminohippurate Sodium | Sodium, Aminohippurate | Sodium Para-Aminohippurate | Para-Aminohippurate, Sodium | Sodium Para Aminohippurate
Chemical Information
Molecular Formula C9H9N2NaO3
CAS Registry Number 94-16-6
SMILES C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blindness17.17.01.003; 06.02.02.001--Not Available
Constipation07.02.02.001--
Corneal degeneration06.06.03.001--Not Available
Nausea07.01.07.001--
Optic neuritis06.04.08.002; 17.04.05.001; 10.04.10.002--Not Available
Papilloedema24.03.07.001; 17.07.02.004; 06.09.02.002--
Photosensitivity reaction23.03.09.003--
Visual field defect17.17.01.001; 06.02.07.003--Not Available
Vomiting07.01.07.003--
Ocular discomfort06.08.03.008--Not Available
Optic neuropathy17.04.05.005; 06.02.08.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
The 1th Page    1    Total 1 Pages